Novo Nordisk has experienced a 50% drop due to potential tariffs and recent clinical trial results but remains strong in diabetes treatment, insulin, and GLP-1 products. I outline the bull case ...

Danish drugmaker Novo Nordisk has been dethroned by German software giant SAP as Europe’s most valuable company. SAP has soared some 40 per cent over the last year as investors celebrated its ...

Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with ...

Based on SOUL findings, Novo Nordisk submitted a label extension application for Rybelsus ® for CV event risk reduction to the US FDA and EMA. The SOUL trial achieved its primary endpoint ...

Shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) climbed ~95% in the premarket trading on Friday after the Texas-based biotech announced an exclusive license agreement with Novo Nordisk (NVO ...

Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed a $2 billion deal to acquire the global rights to an experimental ...

Credit: Cunaplus_M.Faba via Getty Images. Novo Nordisk has signed a deal worth up to $1bn with Lexicon Pharmaceuticals for the exclusive global rights to LX9851, an experimental oral treatment for ...

Well before market open that morning, Morgan Stanley's Thibault Boutherin knocked his Novo Nordisk price target down to 600 Danish kroner ($86.67) per share; previously, this number was 700 kroner ...

More locations have been categorised as premium parking “in high-demand, densely populated areas, including adjacent to or near public transport infrastructure,” Parkin Company PJSC announced ...

German software company SAP overtook Danish healthcare company Novo Nordisk as Europe’s largest company by market capitalisation on Monday. At 0900 GMT, SAP had a market cap of $340 billion, slightly ...

Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity and diabetes drug, the company announced March 24. The drug, called ...

Patients can purchase a month’s supply for a $499 cash payment. Originally, this reduced price was only available through Novo Nordisk’s DTC pharmacy. Now, the company is expanding that discount to ...